An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT05866445

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05866445
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05866445. Randomized; triple masking; primary purpose treatment. Start 2023-03-15 (actual); primary completion 2025-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
Condition
Hypertension
Intervention (Device)
Wearable BP device
Intervention (Device)
24-hour ambulatory blood pressure monitor
Lead sponsor
National Heart Centre Singapore (class: other)

Record details

Record id
cardio:ct-nct05866445
Content hash
92fe5158e2bdaf5df904d6b4ac6d8d614f9198a8719b7b53713f29fd8ad21e35